# Platelet Drug Trial in Coronary Disease Progression

> **NCT00000496** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia

## Interventions

- **DRUG:** aspirin
- **DRUG:** dipyridamole

## Key facts

- **NCT ID:** NCT00000496
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1979-12
- **Primary completion:** —
- **Final completion:** 1982-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000496, "Platelet Drug Trial in Coronary Disease Progression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*